The Ala541Thr variant led to reduced ELAC2 activity that resulted in impaired mitochondrial and nuclear tRNA processing and validated the role of ELAC2 [50], causing prostate hyperplasia and inflammation with age, but not prostate cancer [61]. The gene discussed is ELAC2; the disease is prostate disorder.